PLUS1
3.62
0.12 (3.43%)
0.12 (3.43%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Akers Biosciences Inc | AKER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.10 | 2.94% | 3.50 | 3.36 | 3.69 | 3.36 | 3.40 | 00:00:01 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.52 | 3.80 | 0.28 | 7.37% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,926 | 819,061 | $ 3.53 | $ 2,887,956 | 1,371,597 | 0.2601 - 8.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:24:00 | 20 | $ 3.62 | USD |
Akers Biosciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 21.43M | 6.12M | 5.21M | $ 1.58M | $ - | -6.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 7.30% |
Akers Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/26/2020 | 06:23 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 5/22/2020 | 17:02 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) |
| 5/21/2020 | 15:02 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without.. |
| 5/19/2020 | 06:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/18/2020 | 17:33 | GlobeNewswire Inc. | Akers Biosciences Closes $4.8 Million Registered Direct.. |
| 5/18/2020 | 06:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/18/2020 | 06:08 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.30 | 3.77 | 3.15 | 3.46 | 632,086 | 0.20 | 6.06% |
| 1 Month | 3.57 | 5.50 | 3.10 | 3.56 | 1,674,397 | -0.07 | -1.96% |
| 3 Months | 2.22 | 8.85 | 1.55 | 4.50 | 2,591,853 | 1.28 | 57.66% |
| 6 Months | 8.00 | 8.85 | 1.55 | 4.41 | 1,319,101 | -4.50 | -56.25% |
| 1 Year | 0.6031 | 8.85 | 0.2601 | 3.98 | 741,417 | 2.90 | 480.33% |
| 3 Years | 1.45 | 8.85 | 0.122 | 0.8066064 | 2,866,188 | 2.05 | 141.38% |
| 5 Years | 4.46 | 8.85 | 0.122 | 0.828319 | 1,748,594 | -0.96 | -21.52% |
Akers Biosciences Description
| Akers Biosciences Inc is engaged in developing, manufacturing and supplying rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner. The pipeline products of the company focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious disease detection. The majority of the company's revenue comes from the United States. |
